Form DEF 14A bioAffinity
Technologies For: 16 March
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
bioAffinity Technologies Inc (BIAF)
Track the bioAffinity Technologies share price today and view real-time BIAF share price data, including charts, technicals, and key financials. View the BIAF premarket stock price ahead of the market session or assess the after hours quote. Explore BIAF stock price movements, trading volume, and market activity across the NASDAQ exchange.
What Is the bioAffinity Technologies Stock Price Today?
The bioAffinity Technologies stock price today is 2.740.
What Is the Stock Symbol for bioAffinity Technologies?
The stock symbol for bioAffinity Technologies is ""BIAF.""
What Stock Exchange Does bioAffinity Technologies Trade On?
bioAffinity Technologies is listed and trades on the NASDAQ stock exchange.
Is bioAffinity Technologies a Good Stock to Buy?
Determining whether bioAffinity Technologies or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BIAF quote. (ISIN: US09076W3079)
What Is the bioAffinity Technologies Stock Price Today?
The bioAffinity Technologies stock price today is 2.740.
What Is the Stock Symbol for bioAffinity Technologies?
The stock symbol for bioAffinity Technologies is ""BIAF.""
What Stock Exchange Does bioAffinity Technologies Trade On?
bioAffinity Technologies is listed and trades on the NASDAQ stock exchange.
Is bioAffinity Technologies a Good Stock to Buy?
Determining whether bioAffinity Technologies or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BIAF quote. (ISIN: US09076W3079)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.230
3.090
52 wk Range
0.693
46.530
Unusual Post-Market activity
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.2303.090
52 wk Range
0.69346.530
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BIAF Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
0.000
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form 8K bioAffinity Technologies Inc For: 13 March
- Investing.com
- Form DEF 14A bioAffinity Technologies For: 16 March
- Investing.com
- Form 8K bioAffinity Technologies Inc For: 13 March
- Investing.com
- Form PRE 14A bioAffinity Technologies For: 5 March
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person’s sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.
Compare BIAF to Peers and Sector
Metrics to compare | BIAF | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBIAFPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.8x | −4.0x | −0.5x | |
PEG Ratio | −0.01 | −0.54 | 0.00 | |
Price/Book | 1.7x | 8.1x | 2.6x | |
Price / LTM Sales | 2.0x | 8.9x | 3.1x | |
Upside (Analyst Target) | - | 60.2% | 53.1% | |
Fair Value Upside | Unlock | 7.0% | 6.9% | Unlock |
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 0.000
Earnings
Latest Release
Mar 13, 2026
EPS / Forecast
-0.70 / -0.0857
Revenue / Forecast
1.59M / 1.59M
People Also Watch
FAQ
What Is the bioAffinity Technologies (BIAF) Stock Price Today?
The bioAffinity Technologies stock price today is 2.740 USD.
What Stock Exchange Does bioAffinity Technologies Trade On?
bioAffinity Technologies is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for bioAffinity Technologies?
The stock symbol for bioAffinity Technologies is "BIAF."
What Is the bioAffinity Technologies Market Cap?
As of today, bioAffinity Technologies market cap is 8.580M USD.
What Is bioAffinity Technologies's Earnings Per Share (TTM)?
The bioAffinity Technologies EPS (TTM) is -8.663.
When Is the Next bioAffinity Technologies Earnings Date?
bioAffinity Technologies will release its next earnings report on 14/11/2025.
From a Technical Analysis Perspective, Is BIAF a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has bioAffinity Technologies Stock Split?
bioAffinity Technologies has split 1 times.
How Many Employees Does bioAffinity Technologies Have?
bioAffinity Technologies has 57 employees.
What is the current trading status of bioAffinity Technologies (BIAF)?
As of 17/03/2026, bioAffinity Technologies (BIAF) is trading at a price of 2.740 USD, with a previous close of 1.910 USD. The stock has fluctuated within a day range of 2.230 USD to 3.090 USD, while its 52-week range spans from 0.693 USD to 46.530 USD.
What Is the BIAF Premarket Price?
BIAF's last pre-market stock price is 2.240 USD. The pre-market share volume is 14,670,000.000, and the stock has decreased by 0.330, or 17.260%.
What Is the BIAF After Hours Price?
BIAF's last after hours stock price is 2.600 USD, the stock has decreased by -0.140, or -5.110%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.